Novo Nordisk Foundation to boost pandemic prevention

The Novo Nordisk Foundation wants to arm Denmark against future pandemics, and is granting up to DKK 2bn (USD 310m) to develop an infectious disease center focusing on vaccine development.
Mads Krogsgaard Thomsen, CEO at the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH
Mads Krogsgaard Thomsen, CEO at the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH
by elizabeth mønsted johansen, translated by catherine brett

In order to strengthen Denmark's defences against future pandemics, and the continued fight against Covid-19, the Novo Nordisk Foundation is establishing a new infectious diseases center in the country.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading